About the journal
Theranostics is an open-access journal published by Ivyspring International Publisher in Australia, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,500 AUD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Ivyspring International Publisher
- ISSN
- 1838-7640
- Country
- Australia
- Languages
- english
- Access
- Open access
- Declared publication charge
- 4,500 AUD
- Articles in DOAJ
- 153
- Declared review time
- 12 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.thno.org
Index listings
- DOAJ · 2018-05-02
- MEDLINE · 2011-01-01
- PUBMED · 2011-01-08
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 4,500 AUD
- Declared review time (DOAJ)
- 12 weeks
- Actual review time (measured)
- 114 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
153
Most recent article
14 years ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
5557
Last recorded publication year
2026
h-index
225
i10-index
4514
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2024-02-12
- Added to DOAJ
- 2018-05-02
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMC
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101552395
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Extracellular vesicles in disease
- Extracellular vesicles in disease
- MicroRNA in disease regulation
- MicroRNA in disease regulation
Show all subjects (50)
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Photoacoustic and Ultrasonic Imaging
- Photoacoustic and Ultrasonic Imaging
- Cancer, Hypoxia, and Metabolism
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune cells in cancer
- Radiopharmaceutical Chemistry and Applications
- Ultrasound and Hyperthermia Applications
- Radiopharmaceutical Chemistry and Applications
- Ultrasound and Hyperthermia Applications
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- Circular RNAs in diseases
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Photodynamic Therapy Research Studies
- Photodynamic Therapy Research Studies
- Peptidase Inhibition and Analysis
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Advanced Nanomaterials in Catalysis
- Advanced Nanomaterials in Catalysis
- Ubiquitin and proteasome pathways
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Ubiquitin and proteasome pathways
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
Keywords (DOAJ)
- in vitro diagnostics and prognostics
- in vivo molecular imaging
- molecular therapeutics
- image-guided therapy
- biosensors
- personalized medicine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ